Government Healthcare
-
Learn MoreNovember 2020 Clinical Watch Newsletter
-
Learn MoreCMdS Overview
-
Learn MoreMoving Medicaid Forward
-
Explore our Clinical Watch Newsletter
Learn More -
Learn MoreOctober 2020 Clinical Watch Newsletter
-
Learn MoreKansas Selects Conduent to Manage Medicaid Eligibility and Applications
Six -year contract will support state’s Medicaid and Children’s Health Insurance programs , employ ing more than 400 people in Topeka Selection comes as Medicaid enrollment is rising nationally...
-
Learn MoreSeptember 2020 Clinical Watch Newsletter
-
Learn MoreA Closer Look at Advances in Hemophilia Treatment
-
Learn MoreJoin us for NASCIO’s 2020 virtual annual conference
-
Learn MoreInteroperability Exchange (IOX) Solution Brochure
-
Learn MoreAugust 2020 Clinical Watch Newsletter
-
Learn MoreJuly 2020 Clinical Watch Newsletter
In this issue of Clinical Watch, we discuss new antipsychotic medication formulations to tailor the management of schizophrenia and suggest prior authorization criteria for a new treatment for Cushing
-
Learn MoreFive elements to consider when implementing an Electronic Visit Verification (EVV) Program
Conduent can help states to swiftly and seamlessly implement their Electronic Visit Verification EVV Program. Learn how.
-
Learn MoreJune 2020 Clinical Watch Newsletter
In this issue of Clinical Watch, we discuss nitrosamine impurities found in widely used medications and suggest prior authorization criteria for a new treatment for heavy menstrual bleeding
-
Learn MoreeBook: Helping Government Meet COVID-19 Crisis Demands
-
Learn MoreMay 2020 Clinical Watch Newsletter
In this issue of Clinical Watch, we highlight the use of diabetes drugs in the treatment of heart failure and suggest prior authorization criteria for the first approved treatment of plexiform neurofi
-
Learn MoreFive Things to Know about Contact Tracing as a Service
-
Learn MoreApril 2020 Clinical Watch Newsletter
In this issue of Clinical Watch, we highlight the NIH Panel recommendations regarding medications associated with COVID-19 treatment and suggest prior authorization criteria for the first approved tre
-
Learn MoreMarch 2020 Clinical Watch Newsletter
In this issue of Clinical Watch, we highlight aspects of Medicaid programs that are affected COVID-19 and suggest prior authorization criteria for a new lipid-lowering drug.
-
Learn MoreInfographic: How Contact Tracing Works
To successfully reopen the U.S. economy, public health agencies must perform extensive contact tracing to keep new cases of the virus from growing into a larger outbreak.
-
Learn MoreeBook: Understanding Maven Contact Tracing
The need for timely, accurate information-sharing among key healthcare stakeholders is crucial to preventing the spread of COVID-19.
-
Loading More...
